Randomized controlled clinical trials are regulatory agencies’ preferred approach for registrational studies in new drug and biologics development. However, there are circumstances in oncology when a single-arm trial may be more appropriate. Check the Citeline summary on the key Veristat presentation on the topic > https://bit.ly/45GAIwv #singlearmtrial #oncology
